Authors:
Sharma, A
Mani, S
Hanna, N
Guha, C
Vikram, B
Weichselbaum, RR
Sparano, J
Sood, B
Lee, D
Lee, D
Regine, W
Muhodin, M
Valentino, J
Herman, J
Desimone, P
Arnold, S
Carrico, J
Rockich, AK
Warner-Carpenter, J
Barton-Baxter, M
Citation: A. Sharma et al., An open-label, phase I, dose-escalation study of tumor necrosis factor-alpha (TNFerade (TM) biologic) gene transfer with radiation therapy for locally advanced, recurrent, or metastatic solid tumors, HUM GENE TH, 12(9), 2001, pp. 1109-1131
Authors:
Nag, S
Cano, ER
Demanes, DJ
Puthawala, AA
Vikram, B
Citation: S. Nag et al., The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for head-and-neck carcinoma, INT J RAD O, 50(5), 2001, pp. 1190-1198
Citation: B. Vikram, American Brachytherapy Society recommendations for clinical implementationof NIST-1999 standards for palladium-103 brachytherapy, INT J RAD O, 49(3), 2001, pp. 898-899
Citation: B. Vikram, Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma, J NAT CANC, 92(8), 2000, pp. 657-657
Authors:
Fan, ZH
Chakravarty, P
Alfieri, A
Pandita, TK
Vikram, B
Guha, C
Citation: Zh. Fan et al., Adenovirus-mediated antisense ATM gene transfer sensitizes prostate cancercells to radiation, CANC GENE T, 7(10), 2000, pp. 1307-1314
Citation: R. Yaparpalvi et al., Clinical experience with routine diode dosimetry for electron beam radiotherapy, INT J RAD O, 48(4), 2000, pp. 1259-1265
Citation: B. Vikram, Regarding Blasko et al. Pallidium-103 brachytherapy for prostate carcinoma. IJROBP 2000;46 : 839-850, INT J RAD O, 48(4), 2000, pp. 1267-1267
Authors:
Achary, MP
Jaggernauth, W
Gross, E
Alfieri, A
Klinger, HP
Vikram, B
Citation: Mp. Achary et al., Cell lines from the same cervical carcinoma but with different radiosensitivities exhibit different cDNA microarray patterns of gene expression, CYTOG C GEN, 91(1-4), 2000, pp. 39-43
Authors:
Vikram, B
Deore, S
Beitler, JJ
Sood, B
Mullokandov, E
Kapulsky, A
Fontenla, DP
Citation: B. Vikram et al., The relationship between dose heterogeneity ("hot" spots) and complications following high-dose rate brachytherapy, INT J RAD O, 43(5), 1999, pp. 983-987
Citation: Jj. Beitler et al., Experience-based demand scheduling - A more efficient model for radiation oncology, AM J CL ONC, 22(6), 1999, pp. 554-558
Authors:
Chakravarty, PK
Alfieri, A
Thomas, EK
Beri, V
Tanaka, KE
Vikram, B
Guha, C
Citation: Pk. Chakravarty et al., Flt3-ligand administration after radiation therapy prolongs survival in a murine model of metastatic lung cancer, CANCER RES, 59(24), 1999, pp. 6028-6032
Authors:
Guha, C
Sharma, A
Gupta, S
Alfieri, A
Gorla, GR
Gagandeep, S
Sokhi, R
Roy-Chowdhury, N
Tanaka, KE
Vikram, B
Roy-Chowdhury, J
Citation: C. Guha et al., Amelioration of radiation-induced liver damage in partially hepatectomizedrats by hepatocyte transplantation, CANCER RES, 59(23), 1999, pp. 5871-5874
Authors:
Lee, WR
Berkey, B
Marcial, V
Fu, KK
Cooper, JS
Vikram, B
Coia, LR
Rotman, M
Ortiz, H
Citation: Wr. Lee et al., Anemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck carcinoma: A secondary analysis of RTOG 85-27, INT J RAD O, 42(5), 1998, pp. 1069-1075